ESHRE Virtual 37th Annual Meeting

Tri-component lifestyle intervention benefits women with PCOS

Audrey Abella, 20210728100000

A three-component lifestyle intervention (LSI) programme* was effective in improving the metabolic health and weight of reproductive-aged women with polycystic ovarian syndrome (PCOS), according to data presented at ESHRE 2021.

OTC painkiller use during pregnancy tied to adverse infant outcomes

Pearl Toh, 20210724150000

Use of over-the-counter (OTC) painkillers during pregnancy is associated with an increased risk of adverse neonatal outcomes, suggests a large retrospective study presented at ESHRE 2021.

Short delay in IVF start may not affect live birth rates

Roshini Claire Anthony, 20210719160001

A delay of up to 180 days in initiating in vitro fertilization (IVF) does not appear to affect live birth rates among women with infertility and diminished ovarian reserve, according to a retrospective cohort study presented at ESHRE 2021.

COVID-19 infection unlikely to hinder IVF success

Pearl Toh, 20210717141000

COVID-19 infection does not appear to adversely affect ovarian reserve, and thus, the chance of success from assisted reproductive treatment likely remains the same as before infection, suggests a small study presented at ESHRE 2021.

Linzagolix maintains long-term benefit in women with uterine fibroids

Elaine Soliven, 20210717000000

Linzagolix treatment continues to reduce menstrual blood loss (MBL) and pain severity, while improving haemoglobin (Hb) level and quality of life (QoL) up to 52 weeks in women with uterine fibroids, according to two phase III randomized clinical trials presented at ESHRE 2021.

Artificial cycle frozen-thawed embryo transfer may up preeclampsia, hypertension risk

Roshini Claire Anthony, 20210715180001

Women who undergo artificial cycle frozen-thawed embryo transfer (AC-FET) may have an elevated risk of preeclampsia and pregnancy-induced hypertension (PIH) compared with women who undergo ovulatory cycle frozen-thawed embryo transfer (OC-FET) or in vitro fertilization-fresh transfer (fresh-ET), according to a nationwide cohort study from France presented at ESHRE 2021.

No increased cancer risk in ART-conceived children

Elaine Soliven, 20210714000000

The risk of cancer is not elevated in children and young adults who were conceived after assisted reproductive technology (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and fresh or frozen embryo transfer, compared with those conceived naturally, according to a study presented at ESHRE 2021.

Reduction in endometriosis-associated pain sustained with relugolix combo therapy

Elaine Soliven, 20210713000000

The combination of relugolix 40 mg plus oestradiol 1 mg and norethindrone acetate 0.5 mg (relugolix-CT) continued to reduce dysmenorrhoea and non-menstrual pelvic pain (NMPP) through 52 weeks in premenopausal women with endometriosis, according to the SPIRIT extension* study presented at ESHRE 2021.

Alcohol intake may reduce ability to conceive

Elvira Manzano, 20210707000000

Even moderate alcohol intake, particularly during the second half of the menstrual cycle, should be avoided by women who want to get pregnant, according to a new study that was touted as the first to look at fecundability during the menstrual cycle phases.

Survey says – there’s little evidence of efficacy for fertility add-ons

Elvira Manzano, 20210705091000

A retrospective study of IVF* patients in Australia reveals that 82 percent of women have used one or more fertility add-ons despite limited evidence of efficacy.